首页> 外文期刊>European journal of clinical investigation >Portal vein omentin is increased in patients with liver cirrhosis but is not associated with complications of portal hypertension
【24h】

Portal vein omentin is increased in patients with liver cirrhosis but is not associated with complications of portal hypertension

机译:肝硬化患者门静脉网膜蛋白增加,但与门静脉高压症并发症无关

获取原文
获取原文并翻译 | 示例
           

摘要

Background Omentin is a visceral fat-derived adipokine associated with endothelium-dependent vasodilation. Impaired endothelial function is a major cause of portal hypertension in liver cirrhosis. The aim was to assess associations of omentin with systemic markers of endothelial function, namely arginine and asymmetric dimethylarginine (ADMA) and complications of portal hypertension in liver cirrhosis.
机译:背景Omentin是一种内脏脂肪衍生的脂肪因子,与内皮依赖性血管舒张相关。内皮功能受损是肝硬化门脉高压的主要原因。目的是评估网膜蛋白与内皮功能的系统性标志物,即精氨酸和不对称二甲基精氨酸(ADMA)和肝硬化门静脉高压症的并发症之间的关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号